The prevalence of obesity has markedly increased over the past few decades. Exploration of how hunger and satiety signals influence the reward system can help us understand non-homeostatic feeding. Insulin may act in the ventral tegmental area (VTA), a critical site for reward-seeking behavior, to suppress feeding. However, the neural mechanisms underlying insulin effects in the VTA remain unknown. We demonstrate that insulin, a circulating catabolic peptide that inhibits feeding, can induce long-term depression (LTD) of mouse excitatory synapses onto VTA dopamine neurons. This effect requires endocannabinoidmediated presynaptic inhibition of glutamate release. Furthermore, after a sweetened high-fat meal, which elevates endogenous insulin, insulin-induced LTD is occluded. Finally, insulin in the VTA reduces food anticipatory behavior in mice and conditioned place preference for food in rats. Taken together, these results suggest that insulin in the VTA suppresses excitatory synaptic transmission and reduces anticipatory activity and preference for food-related cues.
a r t I C l e S
Obesity is now recognized as a serious public health issue because of its increasing prevalence and serious comorbidities, including type 2 diabetes, cancer and cardiovascular diseases 1 . Obesity results from energy consumption that exceeds energy expenditure. Although much research has focused on central nervous system regulation of body weight homeostasis and metabolism, this system does not work well in an environment where little effort is required to procure palatable food with high caloric density. Dopamine neurons of the ventral tegmental area (VTA) have been implicated in the incentive, reinforcing, and motivational aspects of food intake 2 . Synapses onto VTA dopamine neurons can undergo both long-term potentiation (LTP) and longterm depression (LTD) to regulate their synaptic strength and consequent dopaminergic output 3, 4 . Enhanced synaptic efficacy of these neurons has been linked not only to exposure to drugs of abuse but to feeding-related peptides, such as hypocretin (orexin) 5, 6 and ghrelin 7 . Potentiation of synaptic strength of dopamine neurons by feedingpromoting peptides may underlie motivation to obtain food 5, 8 .
Normal feeding is regulated by the circulating catabolic peptides, insulin and leptin, that transmit satiety signals to the brain. Insulin is released into the circulation after ingestion of a meal and, along with leptin, may signal the cessation of eating by action in the ventromedial hypothalamus in response to changes in energy homeostasis 9 . Insulin gains access to the brain by active transport across the blood-brain barrier 10 , and its effects are mediated by signaling through insulin receptors expressed throughout the brain 9 . Insulin binds to a singlepass tyrosine kinase membrane receptor, resulting in dimerization and activation of the receptor's intrinsic kinase domain. Insulin-response substrates are phosphorylated and then mediate intracellular signaling cascades and transcription.
Whereas leptin can inhibit firing of dopamine neurons and reduce dopaminergic output 11, 12 , little is known about how insulin interacts with dopamine neurons in the VTA. Several lines of evidence suggest that insulin may alter activity of VTA dopamine neurons. Insulin receptors are expressed on dopamine neurons 13 . When administered intracerebroventricularly, insulin decreases motivation to obtain sucrose 14 and inhibits conditioned place preference (CPP) associated with highfat food 15 . Insulin administered directly into the VTA inhibits opioidinduced feeding 16 and palatable food ingestion 17, 18 . Furthermore, insulin in the VTA increases the threshold for intracranial self-stimulation 19 . Therefore, although insulin appears to modulate appetitive behavior, it is unknown how insulin modulates excitatory synaptic transmission of dopamine neurons. Modulation of excitatory inputs onto VTA dopamine neurons is particularly important, as these inputs tightly regulate dopamine neuronal firing and, ultimately, dopamine release 20 . To elucidate the potential contributions of insulin signaling to neuroplasticity in the VTA, we explored the effects of insulin on excitatory synaptic transmission onto VTA dopamine neurons.
RESULTS

Insulin depresses excitatory synaptic transmission
The VTA receives glutamatergic inputs from regions including the lateral hypothalamus, prefrontal cortex, lateral dorsal tegmentum and peduncle pontine nucleus 21 . We evoked excitatory postsynaptic currents (EPSCs) from unspecified glutamatergic inputs using a r t I C l e S a bipolar stimulating electrode placed 100-300 µm rostral to the recording electrode on VTA dopamine neurons recorded from mouse horizontal midbrain slices. Bath application of insulin (500 nM, 10 min) 22, 23 induced long-term depression (LTD) of evoked EPSCs amplitude (Fig. 1a) . To determine whether insulin-induced LTD required insulin receptor signaling, we interfered with insulin receptor activation in two ways. Both intracellular application of a tyrosine kinase inhibitor, (2-hydroxynaphthalen-1-yl)methylphosphonic acid (HNMPA; 300 µM) 24 , or bath application of an insulin receptor antagonist 25 , S961 (1 µM), blocked insulin-induced LTD (Fig. 1a) . Because insulin is also known to target insulin-like growth factor receptors (IGFR) in the brain 26 , we blocked IGFR activation using picropodophyllotoxin (PPP; 0.5 µM). In the presence of PPP, insulin-induced LTD was not significantly different from controls (P > 0.05, t-test comparing maximal effects at 40 min of PPP-treated versus control). Insulin-induced LTD was concentration dependent, with an IC 50 of 17 ± 1 nM mean ± s.e.m.; (Fig. 1b) . To determine whether insulininduced LTD was due to ineffective insulin washout from midbrain slices, we bath applied cell-permeable HNMPA[AM] 3 (1 µM; Fig. 1c ) or S961 (300 µM; Fig. 1d ) 10 min after washout of insulin. Insulininduced LTD was not reversed by either antagonist.
Next, we determined whether insulin alters NMDA receptor (NMDAR)-mediated EPSCs while voltage-clamping dopamine neurons at +40 mV. Insulin (500 nM, 10 min) caused a long-lasting depression of NMDAR EPSCs to a maximum of 36 ± 5% (Fig. 1e) . The time course or maximal effect was not significantly different than that for insulin-induced LTD of AMPA receptor (AMPAR) EPSCs (P > 0.05; t-test comparing areas under the curve). Taken together, these results indicate that insulin suppressed both AMPAR and NMDAR EPSCs of VTA dopamine neurons.
We next investigated whether insulin could affect inhibitory synaptic transmission onto these neurons. Insulin did not modify GABA Amediated inhibitory postsynaptic currents (IPSCs) onto dopamine neurons ( Fig. 1f ; P > 0.05, t-test comparing maximal effect at 40 min to control (Fig. 1a) ), suggesting that insulin-induced LTD occurred selectively at excitatory synapses.
Insulin-induced LTD requires activation of Akt and mTOR
Insulin receptor activation triggers a variety of signal transduction cascades upon dimerization, autophosphorylation and recruitment of insulin receptor substrates. One pathway involves activation of phosphatidylinositol 3-kinase (PI3K) and subsequent stimulation of the kinase Akt, which triggers activation of mammalian target of rapamycin (mTOR) 27 , a mediator that has been implicated in AMPAR-LTD of VTA dopamine neurons 28 . Rapamycin (50 nM), an inhibitor of mTOR, significantly blocked insulin-induced LTD ( Fig. 2a,b ) in comparison to controls ( Fig. 1a , P < 0.05, t-test of maximal effects at 40 min). Insulininduced LTD was also abolished in the presence of the intracellularly applied Akt antagonist 10-DEBC in comparison to controls (20 µM; Fig. 2a ,b, P < 0.05, t-test of maximal effects at 40 min).
In contrast, insulin-induced LTD was unaffected in the presence of the protein kinase A inhibitor, PKI (20 µM; Fig. 2a,b ; P > 0.05, t-test of maximal effects at 40 min). Figure 2b summarizes the maximal effect 20 min after insulin application. A one-way ANOVA with a Dunnett's post hoc test comparing treatments to the control demonstrated that the effect of insulin in 10-DEBC or rapamycin was significantly different than insulin alone (F 3,24 = 6.3, (q = 3.8, P < 0.01), (q = 3.0, P < 0.05), respectively). These data suggest that the Akt-mTOR pathway was required for insulin-induced LTD in VTA dopaminergic neurons.
Insulin-induced LTD is not mediated by AMPAR trafficking
Insulin-induced LTD in hippocampal and cerebellar neurons involves internalization of AMPARs 22, 23, 29 . Therefore, we tested whether insulin-induced LTD in the VTA occurred by means of activitydependent internalization. This process requires AMPAR sequestration through a clathrin-dependent mechanism, association with dynamin and amphiphysin, and consequent dephosphorylation of components of the endocytotic machinery 30 . We applied the inhibitory peptides GluA2 3Y (100 µg ml −1 ; Fig. 3a . 1a ). Furthermore, intracellular application of D15, a peptide that disrupts the interaction between dynamin and amphiphysin 31 , did not significantly alter the magnitude of insulin-induced LTD in VTA dopamine neurons (37 ± 9% decrease 30 min after insulin application; Fig. 3c,d ; P > 0.05; t-test comparing maximal effect at 40 min in D15-treated cells with that of controls). LTD of synapses of dopamine neurons in the VTA can also be induced by low-frequency stimulation of glutamatergic afferents (LFS-LTD; Fig. 3e ,f) 3 . Intracellular application of D15, but not the scrambled peptide S15, abolished LFS-LTD compared to controls in dopamine neurons ( Fig. 3e,f) . Taken together, these results suggest that whereas D15 blocked conventional LFS-LTD in the VTA, insulininduced LTD occurred by some other mechanism.
Insulin LTD requires retrograde endocannabinoid signaling LTD in the VTA can be mediated postsynaptically, as described above, or by a presynaptic inhibition of glutamate release 32 . Therefore, to investigate whether insulin altered the number and/or function of postsynaptic AMPARs or caused a presynaptic inhibition of glutamate release, we measured AMPAR-mediated miniature EPSCs (mEPSCs), a standard method for determining the locus of synaptic change 33 . Twenty minutes after bath application of insulin (500 nM, 10 min), mEPSCs frequency was significantly lower than that in untreated slices (ACSF, 10 min) ( Fig. 4 ; P < 0.01; t-test comparing frequency of mEPSCs from ACSF-versus insulin-treated cells). Furthermore, we detected a significant right shift in the cumulative probability of mEPSC frequency in insulin-treated slices as compared to control slices ( Fig. 4e ; P<0.001, Kolmogorov-Smirnov test). Insulin did not alter mEPSCs amplitude compared to that in untreated slices ( Fig. 4a,d ,f; P>0.05; t-test comparing amplitude of mEPSCs from ACSF-versus insulin-treated cells). A reduction of mEPSCs frequency concomitant with unchanged amplitude likely reflects a decrease in the probability of presynaptic neurotransmitter release 33 . To further verify whether insulin-induced depression of AMPARs was mediated pre-or postsynaptically, we examined the response to paired pulses (50 ms interval), a measure that changes in a highly predictable fashion with release probability. We observed significant paired-pulse facilitation after insulin bath application ( Fig. 4g ; P < 0.001, F 7,4,28 = 8.3, repeated measures ANOVA). Thus, insulin-induced depression of AMPAR-mediated synaptic transmission resulted from a reduced probability of glutamate release.
Antagonists of the insulin receptor signaling pathway administered postsynaptically were sufficient to block insulin-induced LTD, yet insulin caused a presynaptic depression of glutamate release. Therefore, we hypothesized that postsynaptic insulin receptor activation may initiate a retrograde signaling mechanism. Endocannabinoids synthesized postsynaptically act at presynaptic cannabinoid 1 receptors * npg a r t I C l e S (CB1Rs) in a retrograde manner to mediate presynaptic inhibition of glutamate release in several brain regions, including the VTA 34, 35 . We tested whether the insulin-induced inhibition of glutamate release probability was blocked in the presence of a CB1R antagonist, AM251 (2 µM, bath applied 5 min before insulin and for the duration of the experiment). Insulin did not significantly alter mEPSCs frequency ( Fig. 4b ,c,f; P > 0.05; t-test comparing frequency of mEPSCs from ACSF versus insulin treated cells) or amplitude ( Fig. 4b,d ,f; P > 0.05; t-test comparing amplitude of mEPSCs from ACSF-versus insulintreated cells) in the presence of AM251.
To determine whether CB1R activation was required for insulininduced LTD, we bath-applied AM251 (2 µM) 5 min before insulin (500 nM, 10 min) and for the duration of the experiment. Insulin-induced LTD was significantly lower than that in controls (AM251 with insulin, 10 ± 7%; insulin alone, 40 ± 3% decrease 30 min after insulin application; Fig. 5a ; P<0.01; t-test). Bath application of a CB1R agonist, WIN 55,232-2 (WIN, 1 µM, 5 min), induced LTD with a similar magnitude as insulin-mediated LTD (44 ± 4% decrease 35 min after WIN application; Supplementary Fig. 1 ; P > 0.05; t-test). To determine whether prior activation of CB1Rs could occlude insulin-induced LTD, we applied WIN 20 min before insulin and for the duration of the experiment. In the presence of WIN, insulininduced LTD did not occur ( Fig. 5b ; P > 0.05; paired t-test of baseline (5 min) versus 30 min after insulin application), suggesting that insulin-induced LTD and CB1R-mediated LTD shared the same mechanism. In the reverse experiment, WIN (1 µM, 5 min) applied 25 min after insulin application did not cause a significant reduction in evoked AMPAR EPSCs ( Fig. 5c ; P > 0.05; paired t-test comparing effect at 40 min versus 70 min).
We also examined, by inhibiting the synthesis of 2-arachidonylglycerol (2-AG), the most abundant endocannabinoid in the midbrain 36 , whether postsynaptic synthesis of endocannabinoids was required for insulin-induced LTD. Intracellular application of the diacylglycerol lipase (DAGL) inhibitor orlistat (2 µM) blocked insulin-induced LTD ( Fig. 5d ; P>0.05; paired t-test of baseline (5 min) compared to 30 min after insulin application). Preincubation with AM251 (q = 4.4, P < 0.001), WIN (q = 4.2, P < 0.001) or intracellular application of orlistat (q = 3.5, P < 0.01) significantly inhibited insulin-induced LTD of AMPAR EPSCs compared to that in controls (F 3,31 = 11.1, one way ANOVA with Dunnett's post hoc test comparing treatments to insulin control). Taken together, these results suggest that insulin receptor activation stimulated 2-AG production resulting in presynaptic CB1R-mediated depression of glutamate release.
In other preparations, endocannabinoid-mediated LTD has been implicated in the induction phase of LTD, as depression of AMPAR EPSCs is resistant to CB1R antagonists several minutes after induction 35 . Application of AM251 ( Fig. 5e ; P > 0.05) or orlistat ( Fig. 5e ; P > 0.05) did not significantly alter AMPAR EPSC amplitude after (c) Frequency of mEPSCs events was decreased after insulin treatment (n = 11 cells, 4 mice) compared to control (ACSF alone; n = 11 cells, 4 mice, **P < 0.01). In the presence of AM251, mEPSCs frequency after insulin treatment (n = 12 cells, 5 mice) was not different from controls (n = 11 cells, 5 mice, P > 0.05 (n.s.)). (d) AMPAR mEPSCs amplitude was not significantly different after insulin treatment (n = 11 cells, 4 mice) compared to controls (n = 10 cells, 4 mice, oneway ANOVA with a Bonferroni multiple comparison test, t = 1.5, P > 0.05) in ACSF or preincubated with AM251 (n = 12 cells, 5 mice) compared to control (n = 11 cells, 4 mice, one-way ANOVA with a Bonferroni multiple comparison test, t = 0.8, P > 0.05). Insulin + AM251 2 µM npg a r t I C l e S insulin-induced LTD (t-tests comparing effect at 30 min versus effect at 55 min), suggesting that endocannabinoids were required for induction of insulin LTD but were no longer required to maintain the LTD.
To determine whether intracellular calcium was required for insulin-induced LTD, the Ca 2+ chelator BAPTA (10 mM) was applied intracellularly for the duration of the experiment. Insulin suppressed AMPAR EPSCs to a similar maximum as that without BAPTA (Fig. 5f) . Furthermore, insulin-induced LTD was still blocked by AM251 in the presence of intracellular BAPTA (Fig. 5f) , suggesting that intracellular Ca 2+ was not required for insulin-induced endocannabinoid LTD.
Insulin LTD is occluded after sweetened high fat exposure
To determine whether a caloric meal, known to elevate plasma insulin, could alter insulin-induced LTD in the VTA, we exposed C57BL/6J mice to unlimited sweetened high-fat pellets (SHF group) or continued access to regular chow (RF group) for 1 h before brain slice preparation. All mice were exposed to 1 g of SHF pellets 48 h before the experiment to habituate them to the novel food. Plasma insulin was significantly greater in the SHF group (2.0 ± 0.4 ng ml −1 , n = 11) than in the RF group (0.8 ± 0.2 ng ml −1 , n = 7, t = 2.7, P < 0.05) or 1 h after the end of SHF exposure (0.7 ± 0.2, n = 9, t = 3.4, P < 0.01) (F 2,24 = 6.8, one-way ANOVA with Bonferroni multiple comparison test).
In contrast to dopamine neurons from RF-fed mice (n = 11), insulin did not induce LTD in VTA dopamine neurons from SHF-fed mice (Fig. 6a , n = 8, P > 0.05; paired t-test comparing baseline at 5 min with 30 min after insulin application). The maximal effects of insulin on AMPAR EPSCs between RF-or SHF-fed mice were significantly different (P < 0.05, t-test). The inability of insulin to induce LTD could be explained by the possibility that insulin was elevated in SHF-fed mice, thus occluding the effects of exogenously applied insulin. To test this hypothesis, we measured mEPSCs from VTA dopamine neurons of mice fed RF or SHF. Compared to mice fed RF (n = 8), mice fed SHF had a significantly lower mEPSC frequency (Fig. 6b , n = 10, P < 0.05, t-test) but no change in mEPSC amplitude in comparison to RF-fed mice ( Fig. 6b, P > 0.05, t-test) . We next tested whether a SHF meal increased endocannabinoid signaling compared to controls. Bath application of the CB1R antagonist AM251 (10 µM) led to a significant increase of AMPAR EPSC amplitude in VTA neurons obtained from SHF-fed mice (n = 6) compared to mice fed RF (n = 9) ( Fig. 6c ; P < 0.05; t-test comparing maximal effect at 30 min between SHF and RF groups). To determine whether continued endocannabinoid synthesis was required for the CB1R-mediated increase in EPSCs after SHF, orlistat was applied intracellularly (2 µM) or externally (10 µM) before, during and after AM251 application ( Fig. 6c) . Intracellular application of orlistat did not significantly alter AM251-induced potentiation in cells from SHF-fed mice (P > 0.05, n = 9; t-test comparing AMPAR EPSCs 20 min after AM251 application with or without orlistat). In contrast, bath application of orlistat blocked AM251-induced potentiation of AMPAR EPSCs in SHF-fed mice (P > 0.05, n = 8, t-test comparing AMPAR EPSCS before (at 5 min) and after (at 30 min) AM251).
Next, we assessed whether insulin-induced LTD was present in VTA dopamine neurons from mice fed SHF or RF (1 h) and then killed 60 min after the food exposure. Insulin-induced LTD was partially restored in mice fed SHF (22 ± 7% inhibition 30 min after insulin application; Fig. 6d,e, P<0.05 , paired t-test comparing baseline at 5 min with maximum at 15 min after insulin application). Insulininduced LTD was significantly different between dopamine neurons from RF-fed mice, SHF-fed mice and those examined 1 h after the SHF meal ( Fig. 6d,e, P<0 .05, one-way ANOVA with Bonferroni post hoc test). Taken together, these results suggest that elevation of insulin by consumption of a caloric meal temporarily disrupts the induction of LTD by exogenously applied insulin in VTA slices.
To determine whether a SHF meal could modulate a dopaminemediated behavior, we examined the effect of 1 h access to SHF or RF on cocaine-induced locomotor activity. As above, mice were given 1 h access to SHF or RF. Mice were then given a systemic injection Mice given 1 h access to SHF exhibited significantly less locomotor activity than did mice fed RF ( Fig. 6f ; RF, 89 ± 8 cm; SHF, 73 ± 8 cm; P < 0.05, one-way ANOVA). There were no significant differences in basal locomotor activity in mice receiving RF (37 ± 2 cm, n = 9) or SHF (34 ± 3 cm, n = 9, repeated-measures ANOVA, F 3,8,24 = 25.2 with a Bonferroni multiple comparison test, t = 2.30, P > 0.05). These data suggest that a SHF meal can reduce cocaine-induced locomotor activity.
Intra-VTA insulin inhibits food-related behaviors
To explore the behavioral relevance of insulin in the VTA, we first assessed whether insulin could modulate food-anticipatory activity. Previous work has demonstrated that mice will increase their locomotor activity before receiving meals 37 , an effect that is accompanied by an increase in dopamine concentration in target regions of the VTA 38 .
We entrained mice to consume their daily caloric intake in 4 h per day between zeit time 6 and 10 (12-4 p.m., Pacific Standard Time).
Once entrainment was established, on the test day we injected mice intra-VTA with insulin (5 mU) 17 or vehicle and then placed them in the entrainment cage, in which food was placed behind a Plexiglas barrier containing four small holes at the base of the barrier. In this experiment, mice had visual and olfactory cues of the food (chow) but were unable to access the food for 15 min. During this time, we recorded food anticipatory activities including cage crossovers as a proxy for locomotor activity, rearing and digging. We also recorded nonspecific behavioral activities such as grooming (Fig. 7a) These data indicate that insulin in the VTA suppressed behavioral activities associated with food-anticipatory behavior. Insulin-induced reduction in activity during anticipation of food may reflect changes in simple appetitive behaviors displayed routinely before consumption of a meal, an effect that is mediated by the salience of food-related cues. Alternatively, insulin may reduce the effort exerted to obtain food. We first tested the latter idea directly by training mice to perform an instrumental response for palatable food under progressive ratio schedule whereby the response requirement to earn sucrose escalates after the delivery of each reinforcer. Intra-VTA insulin (0.065 mU (2 µM)) did not alter the breakpoint for sucrose (2.5%, 10 µl, 24 ± 4 presses) compared to intra-VTA vehicle (26 ± 5 presses, P > 0.05, paired t-test). To determine whether intra-VTA insulin modulates the effort required to obtain a more salient reinforcer, we tested mice with sweetened condensed milk (SCM). Although the breakpoint was significantly greater for SCM than sucrose (P < 0.001, t-test), the breakpoint for SCM was not significantly different between intra-VTA insulin (3.25 mU (100 µM), 315 ± 80 presses) and controls (330 ± 83 presses, P > 0.05, paired t-test). Furthermore, there were no significant differences in cumulative probability for sucrose or SCM between intra-VTA insulin ( Fig. 7b, P > 0 .05, Kolmogorov-Smirnov test). Taken together, these data indicate that insulin in the VTA does not alter the effort exerted to obtain a palatable reinforcer.
Next, we tested whether insulin in the VTA can alter conditioned place preference (CPP) for food. This test depends on the animal learning to associate contextual cues with a food reward 39 . We performed Figure 6 A SHF meal increases endocannabinoid tone and occludes insulin-induced LTD onto VTA dopamine neurons. (a) Insulin did not depress AMPAR EPSCs in VTA dopamine neurons from SHF-fed mice (n = 11 cells, 8 mice) in comparison to those in neurons from RF-fed mice (n = 9 cells, 5 mice). Inset, example recordings of AMPAR EPSCs at 5 (black) and 40 (gray) min for mice fed RF (filled circle) or SHF (open circle). Scale bars, 5 ms and 50 pA. (b) Top: example recordings of AMPAR mEPSCs of VTA dopamine neurons from non-food-restricted mice given 1 h access to RF or 1 h access to SHF. Scale bars, 50 ms and 20 pA. Bottom: mEPSCs frequency was significantly decreased in neurons from mice fed SHF (n = 10 cells, 4 mice) in comparison to RF (open bars, n = 8 cells, 3 mice, t-test, ***P < 0.001). mEPSC amplitude was not significantly different in neurons from mice fed RF (n = 10 cells, 4 mice) in comparison to SHF (n = 8 cells, 3 mice, t-test, P > 0.05 (n.s.)). (c) AM251 increased AMPAR EPSCs amplitude in VTA dopamine neurons from SHF-fed mice (n = 6 cells, 5 mice) but not RF-fed mice (n = 9 cells, 5 mice). Bath application (n = 8 cells, 6 mice), but not intracellular application, of orlistat (n = 9 cells, 7 mice) inhibited the AM251-mediated increase in AMPAR EPSCs. (d) Insulininduced LTD was partially restored in VTA slices cut 1 h after a SHF meal (n = 7 cells, 7 mice). Inset, example traces of AMPAR EPSCs at 5 (black) and 40 (gray) min. Scale bars, 10 ms and 100 pA. (e) Maximal effect of insulin-induced LTD in VTA slices cut immediately after mice were fed RF (n = 11 cells, 5 mice) or SHF (n = 9 cells, 8 mice) or slices cut 1 h after mice were fed SHF (n = 7 cells, 7 mice). One-way ANOVA with a Bonferroni post hoc test indicates a significant difference between RF and immediately after SHF (F 2,19 = 11.75, t = 4.9, **P < 0.01). (f) Cocaine-induced locomotor activity over the course of 15 min was significantly decreased in mice given 1 h access to SHF compared to RF (n = 9 mice, repeated-measures ANOVA, F 3,8,24 = 25.2 with a Bonferroni multiple comparison test, t = 2.30, *P < 0.05). Basal locomotor activity was not significantly different between SHF and RF groups (n.s.; n = 6 mice, t = 0.41, P > 0.05). Stimulus artifacts have been removed for clarity. Error bars represent means ± s.e.m. these experiments in animals fed ad libitum during their light phase to be consistent with our electrophysiological experiments. Unfortunately, we were unable to obtain a reliable CPP in non-food-restricted mice; therefore, we repeated the experiment using rats. As consistent with our results in mice, insulin induced a similar LTD onto VTA dopamine neurons of rats to a maximum of 37 ± 3% 30 min after insulin application (n = 7; Supplementary Fig. 2) . We placed rats initially in a central compartment of the CPP chamber; they had free access to separate compartments defined by specific visual and floor texture contextual cues paired with food (Froot Loops cereal) or no food (unpaired) on alternate days for 8 training days. There were no significant differences in place preference among groups during the pre-test (Fig. 7c , F 2,21 = 0.01, P > 0.05, one-way ANOVA). On the test day (in the absence of Froot Loops), we microinjected insulin (0.005 mU (63 nM) or 0.065 mU (2 µM)) or vehicle into the VTA 5 min before placing the rats in the CPP apparatus and recorded time spent in each chamber. Intra-VTA insulin caused a concentration-dependent decrease in preference score (Fig. 7d , one-way ANOVA with a Dunnett's multiple comparison to control, F 2,18 = 3.4, q = 2.6, P < 0.05). Disruption in CPP supports the proposal that insulin in the VTA reduces the preference for contextual cues associated with food reward.
DISCUSSION
The data presented here establish a mechanism for insulin function in the mesolimbic pathway. Insulin produced an LTD of AMPAR-mediated synaptic transmission onto VTA dopamine neurons. Insulininduced LTD required postsynaptic activation of insulin receptor signaling, synthesis of endocannabinoids and presynaptic CB1R-mediated inhibition of glutamate release. Furthermore, insulin-induced LTD was occluded in mice pre-fed SHF. Insulin in the VTA inhibited food-anticipatory behavior and CPP for food, suggesting that insulin may attenuate activity toward or preference for food-related contexts or cues. These data not only point to a new type of endocannabinoidmediated LTD, they demonstrate that insulin signaling in the VTA depresses synaptic output and modulates ingestive behavior.
Insulin-induced LTD of VTA dopamine neurons
We demonstrated that insulin caused a long-lasting depression of AMPAR-mediated excitatory synaptic transmission onto VTA dopaminergic neurons with concentrations as low as 10 nM. Insulininduced LTD has been reported in other brain regions, including the hippocampus 23 and cerebellum 22 via a clathrin-dependent endocytosis of GluA2-containing AMPARs. In contrast, we demonstrated that insulin-induced LTD was mediated by endocannabinoid retrograde signaling. First, insulin-induced LTD was not blocked by inhibitors to the endocytotic process of AMPARs. Second, insulin-induced LTD as well as insulin-induced reduction in mEPSCs frequency was abolished with AM251, a CB1R antagonist. Third, insulin-or CB1Rmediated depression of AMPAR currents occurred through the same mechanism. Fourth, intracellular application of orlistat, an inhibitor of 2-AG synthesis, blocked insulin-induced LTD. Taken together, we demonstrate a mechanism of insulin-induced LTD requiring retrograde endocannabinoid signaling. Endocannabinoid-mediated LTD has been reported to occur at both excitatory 34 and inhibitory 40 synapses onto VTA neurons. Insulin-induced endocannabinoid-mediated LTD was selective for glutamatergic synapses onto dopamine neurons, as insulin receptor activation did not modify GABA IPSCs. Although it is unclear how this synapse-selective endocannabinoid LTD occurs, one possibility is that GABAergic and glutamatergic synapses are segregated in regions of the VTA, such that endocannabinoids produced near glutamatergic synapses may not reach GABAergic synapses. Of note, distal dendrites of dopamine neurons reaching into the substantia nigra reticulata receive stronger GABAergic input than dendrites nearer the substantia nigra pars compacta, thereby establishing precedence for synaptic segregation influencing neuronal activity within the midbrain 41 . Alternatively, insulin receptors could be preferentially located near glutamatergic synapses. Cell-selective endocannabinoid LTD has been demonstrated at excitatory synapses onto medium spiny neurons of the nucleus accumbens 42 . Taken together, these data indicate that insulin may selectively dampen glutamatergic inputs to the VTA.
Endocannabinoid-mediated LTD is a widespread phenomenon in the brain 34 . Its induction typically requires a transient increase in activity at glutamatergic afferents and concomitant release of endocannabinoids from the postsynaptic neuron. Endocannabinoidmediated LTD can also result from activation of G protein-coupled receptors that signal through Gα q/11 , engaging phospholipase C and DAGL, forming the endocannabinoid 2-AG. Activation of Gα i/ocoupled receptors leading to increases in anandamide has also been demonstrated 35 . Here we demonstrate a form of endocannabinoid LTD that is initiated by activation of a receptor tyrosine kinase, resulting in synthesis and release of 2-AG. Figure 7 Insulin in the VTA decreases food anticipatory activity and conditioned place preference, but not effort. (a) Intra-VTA (i.c.) insulin-treated mice (5 mU, n = 7) had decreased food anticipatory activity measured by cage crossovers (t 6 = 9.8, P < 0.001), time spent rearing (t 6 = 3.4, P < 0.05) and time spend digging (t 6 = 5.7, P < 0.01) than vehicle-treated mice (100%) (n = 7 mice). Grooming was not significantly less in insulin-treated mice (t 6 = 0.9, P > 0.05). (b) Left, cumulative presses for 2.5% sucrose were not significantly different between mice receiving intra-VTA insulin (0.065 mU (2 µM), n = 9 mice) or vehicle (n = 9 mice) (P > 0.05, Kolmogorov-Smirnov test). Right, cumulative presses for SCM were not significantly different between mice receiving intra-VTA insulin (3.25 mU (100 µM), gray line, n = 6 mice) or vehicle (black line, n = 6 mice) (P > 0.05, Kolmogorov-Smirnov test). (c) Pre-test day training did not reveal a significant difference in preference score between groups (n = 9 rats; one-way ANOVA, F 2,21 = 0.01, P > 0.05). (d) Intra-VTA insulin significantly reduced preference scores compared to vehicle (n = 9 rats; one-way ANOVA with a Dunnett's multiple comparison to control, F 2,18 = 3.4, q = 2.6, *P < 0.05). Bars represent means ± s.e.m. a r t I C l e S Although CB1 receptor activation is necessary for the induction of LTD, it is not necessary for its maintenance 35, 43, 44 . Consistent with these studies, LTD was not reversed with application of AM251 or orlistat after exogenously applied insulin. Although WIN caused a long-lasting depression of AMPAR EPSCs, this was not likely to be due to persistent CB1R signaling but rather to the inability to wash out the highly lipophilic drug during the recording period 45 . These results implicate other mechanisms in the maintenance of the LTD, including protein translation at excitatory synapses, as has been demonstrated in the striatum 45 or a presynaptic alteration stabilizing the reduced release probability.
Synaptic depression induced by SHF consumption
We found that synaptic depression onto dopamine neurons also occurred after a SHF meal. Although we are unable to unequivocally state that SHF-induced synaptic depression was directly due to insulin signaling, this effect was consistent with insulin-induced LTD onto dopamine neurons. First, when mice had 1 h access to SHF, plasma insulin was elevated in comparison to that in mice given RF. Second, in comparison to RF-fed mice, SHF-fed mice demonstrated an inability to produce insulin-induced LTD and a decreased probability of glutamate release, suggesting that a SHF meal was sufficient to suppress excitatory synaptic transmission onto VTA dopamine neurons and potentially occlude insulin-induced LTD. Third, only dopamine neurons from mice fed SHF were sensitive to a CB1R antagonist, suggesting an elevated endocannabinoid tone. Indeed, increased N-arachidonoylethanolamine and 2-AG levels were observed in mice fed a long-term high-fat diet 46 . Bath application of orlistat inhibited the AM251-induced potentiation of AMPAR EPSCs after SHF. Postsynaptic application of orlistat did not block AM251-induced potentiation of AMPAR EPSCs. However, intracellular application of orlistat would only block 2-AG production from the recorded neuron, without negating potential increases in 2-AG due to insulin signaling on neighboring dopamine neurons or sources other than dopamine neurons contributing to the elevated endocannabinoid tone. Taken together, these results indicate that the SHF meal induced a suppression of excitatory synaptic transmission onto dopaminergic neurons, likely by increasing endocannabinoid tone.
SHF-induced depression of excitatory synaptic transmission in the VTA was partially reversed in slices cut 1 h after SHF food exposure. Thus, unlike long-lasting synaptic adaptations associated with drugs of abuse 47 , the depression of excitatory synaptic transmission onto dopamine neurons associated with a caloric meal was transient. Notably, 1 h later, plasma insulin levels were significantly less than immediately after SHF, suggesting that the inability of exogenously applied insulin to induce LTD after SHF correlates with plasma insulin levels. Because of insulin's rapid clearance from the circulation by the liver, insulin has a very short half life in vivo 48 . Consequently, concentrations of circulating insulin acting in the VTA may be different than those of intracerebroventricularly applied insulin, resulting in potential differences in the time course of effect. Additionally, in vivo mechanisms may be required to reverse SHF-induced synaptic depression. Indeed, arousal-and feeding-related peptides such as hypocretin or ghrelin have been known to enhance excitatory synaptic efficacy onto VTA dopamine neurons [5] [6] [7] .
Cocaine-induced locomotor activity was reduced in mice receiving a SHF meal in comparison to that in RF-fed controls. This effect is consistent with an increase in plasma insulin, an occlusion of insulin-induced LTD and a reduction of excitatory synaptic transmission onto VTA dopamine neurons after a SHF meal. Notably, this effect only occurred in cocaine-treated mice. Consistent with this, insulin in the VTA did not alter basal locomotor activity. Insulin in the VTA increases transporter number or function, resulting in a decrease in somatodendritic dopamine 18 . Therefore, in addition to a SHF meal reducing excitatory synaptic transmission, it may also reduce dopamine-enhanced locomotor activity.
Intra-VTA insulin reduced activity or preference for food cues Our electrophysiology results indicate that insulin suppressed excitatory synaptic transmission onto VTA dopamine neurons, likely reducing their burst activity, which in turn would attenuate dopamine release in target regions of the mesocorticolimbic dopamine system 49, 50 . Enhanced synaptic efficacy onto VTA dopamine neurons and their consequent burst firing has been associated with learned associations of cues with rewards 48, 49 . Therefore, we hypothesized that insulin in the VTA decreases salience of reward predicting cues. Consistent with this, we found decreased preference for environmental contexts associated with food after intra-VTA insulin treatment, in agreement with reports demonstrating that intracerebroventricular insulin reduces CPP for high-fat food 15 . Unexpectedly, we did not observe a significant effect on effort exerted to obtain sucrose or SCM with 0.065 or 3.25 mU insulin intra-VTA, respectively. Although intra-VTA insulin (5 mU) does not modify lever pressing for sucrose under a fixed ratio schedule 17 , others have reported that intracerebroventricular insulin (5 mU) reduces lever pressing for 5% sucrose under a progressive ratio schedule 14 . Our observation that intra-VTA insulin suppressed food anticipatory behavior was likely an effect of insulin on processes involved in learned associations between visual and/or olfactory stimuli and food rather than those mediating effort required to obtain food per se. Notably, unlike the progressive ratio test, consumption of food was not required for intra-VTA insulin-induced reductions of food anticipation or expression of food place preference. Consumption of RF was not reduced with intra-VTA insulin 18 . Furthermore, plasma insulin after RF feeding was not elevated, nor was exogenous insulin-induced LTD occluded after RF. However, a reduction in sated consumption of SHF is observed after intra-VTA insulin 18 . Therefore, intra-VTA insulin likely induced LTD and thus reduced activity or preference for SHF, resulting in the reduced consumption previously observed 18 .
Here we propose a new mechanism by which insulin reduces excitatory synaptic efficacy onto VTA dopamine neurons. Insulin-induced LTD requires postsynaptic insulin receptor activation, Akt and mTOR signaling, and retrograde endocannabinoid suppression of glutamate release. Furthermore, a SHF meal, which elevates plasma insulin, transiently weakens excitatory synaptic transmission onto dopamine neurons. Finally, insulin in the VTA likely reduces the salience of cues or contexts associated with food. Taken together, these findings provide insights into how insulin can modulate reward circuitry and a new type of endocannabinoid-mediated LTD.
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